September 1st, 2017
The following information from the Medicare Learning Network provides guidance from the Department of Health and Human Services on Screening for Cervical Cancer with Human Papillomavirus (HPV) Tests:
|G0476 -||Infectious agent detection by nucleic acid (DNA or RNA); human papillomavirus (HPV), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test|
Who Is Covered
All asymptomatic female Medicare beneficiaries aged 30 to 65 years
Once every 5 years
Medicare Beneficiary Pays
- Copayment/coinsurance waived
- Deductible waived
- Refer to Screening for Cervical Cancer with Human Papillomavirus (HPV) Testing – National Coverage Determination (NCD) 210.2.1 for more information.
Please note: The information in this educational product applies only to the Medicare Fee-For-Service Program (also known as Original Medicare). For additional guidance on using diagnosis codes, go to the Medicare Claims Processing Manual, Chapter 18 on the Centers for Medicare & Medicaid Services (CMS) website.
Watch the CMS Provider Minute: Preventive Services video for pointers to help you submit sufficient documentation when billing for certain preventive services.